Wang Junmei, Liu Zhaoxia, Du Jiang, Cui Yun, Fang Jingyi, Xu Li, Li Guilin
Department of Neuropathology, Beijing Neurosurgical Institute, Capital Medical University, China National Clinical Research Center for Neurological Diseases, NCRC-ND, Center of Brain Tumor, Beijing Institute for Brain Disorders, Beijing Key Laboratory of Brian Tumor, Beijing, China.
Neuropathology. 2016 Oct;36(5):432-440. doi: 10.1111/neup.12291. Epub 2016 Feb 26.
Pituicytoma is rare and difficult to diagnose. This study explored the clinicopathological features, immunophenotype and differential diagnosis of pituicytoma. We compared 11 cases of pituicytoma and 26 cases of sellar glioma (16 pilocytic astrocytomas, four diffuse astrocytomas, three pilomyxoid astrocytomas, and three third ventricle chordoid gliomas). The 11 pituicytoma cases involved six men and five women (age: 33-65 years). Three of the 11 patients experienced recurrence due to a residual tumor, and one patient underwent three surgeries during a 6-month period. Imaging findings revealed tumors were in the intrasellar region (four cases), suprasellar region (four cases) and intra-suprasellar regions (three cases). The tumor diameters were 1.3-3.8 cm, and the preoperative diagnoses were pituitary adenoma, craniopharyngioma and meningioma. The tumors were solid and contained spindle or slightly chubby cells that were densely arranged with visible cleft-like or expanded sinusoid structures. The cells had vague boundaries, circular nuclei, fine chromatin, and a small nucleolus. Immunohistochemical staining of the pituicytomas revealed positive expression of thyroid transcription factor-1 (TTF-1) and S-100 protein (S-100), positive focal expression of glial GFAP;(five of 11 cases), and negative oligodendrocyte transcription factor 2 (Olig2), CD34 and neurofilament expression. The Ki67 index was 6% in one case and 1-2% in the other cases. Unlike pituicytoma, most sellar glioma cases exhibited GFAP and Olig2 expression, and negative TTF-1 expression. Third ventricle chordoid gliomas expressed TTF-1, GFAP and CD34, and were negative for Olig2. Our results indicate that pituicytoma typically involves dense arrangements of spindle or slightly chubby cells. The morphology is occasionally atypical, with ependymoma-like or meningioma-like structures, and occasionally exhibits pilomyxoid degeneration. Abundant sinusoids are characteristic of hemorrhagic tumors. The dense spindle cell arrangement is a relatively specific morphology, and staining for GFAP, TTF-1, Olig2 and CD4 may help differentiate pituicytoma from sellar glioma.
垂体细胞瘤罕见且难以诊断。本研究探讨了垂体细胞瘤的临床病理特征、免疫表型及鉴别诊断。我们比较了11例垂体细胞瘤和26例鞍区胶质瘤(16例毛细胞型星形细胞瘤、4例弥漫性星形细胞瘤、3例毛黏液样星形细胞瘤和3例第三脑室脊索样胶质瘤)。11例垂体细胞瘤患者中,男性6例,女性5例(年龄:33 - 65岁)。11例患者中有3例因肿瘤残留而复发,1例患者在6个月内接受了3次手术。影像学检查发现肿瘤位于鞍内区域(4例)、鞍上区域(4例)和鞍内 - 鞍上区域(3例)。肿瘤直径为1.3 - 3.8 cm,术前诊断为垂体腺瘤、颅咽管瘤和脑膜瘤。肿瘤质地坚实,包含梭形或稍胖的细胞,这些细胞密集排列,可见裂隙样或扩张的血窦样结构。细胞边界模糊,核圆形,染色质细腻,核仁小。垂体细胞瘤的免疫组化染色显示甲状腺转录因子-1(TTF-1)和S-100蛋白(S-100)呈阳性表达,胶质纤维酸性蛋白(GFAP)呈局灶性阳性表达(11例中有5例),少突胶质细胞转录因子2(Olig2)、CD34和神经丝蛋白表达阴性。Ki67指数在1例中为6%,在其他病例中为1% - 2%。与垂体细胞瘤不同,大多数鞍区胶质瘤病例表现为GFAP和Olig2表达,TTF-1表达阴性。第三脑室脊索样胶质瘤表达TTF-1、GFAP和CD34,Olig2表达阴性。我们的结果表明,垂体细胞瘤通常由密集排列的梭形或稍胖的细胞组成。其形态偶尔不典型,具有室管膜瘤样或脑膜瘤样结构,偶尔表现为毛黏液样变性。丰富的血窦是出血性肿瘤的特征。密集的梭形细胞排列是一种相对特异的形态,GFAP、TTF-1、Olig2和CD4的染色有助于垂体细胞瘤与鞍区胶质瘤的鉴别。